Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Endra Life Sciences Inc. (NDRA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Endra Life Sciences Inc. since year 2005.
Table 2 shows the detailed insider transactions of Endra Life Sciences Inc. since 2005.
The reporting company's ticker symbol is NDRA. The reporting company's CIK number is 1681682.
The total value of stock buying since 2005 is $72,402.
The total value of stock sales since 2005 is $545,263.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-27||Wells David R. (Chief Financial Officer)||Buy||10,000||1.18||11,800|
|2019-08-23||Wells David R. (Chief Financial Officer)||Buy||5,000||1.55||7,750|
|2019-08-22||Wells David R. (Chief Financial Officer)||Buy||5,000||1.56||7,800|
|2019-06-10||Harsh Michael (Director)||Buy||500||1.14||570|
|2019-06-07||Harsh Michael (Director)||Buy||2,800||1.12||3,136|
|2019-06-06||Harsh Michael (Director)||Buy||6,600||1.11||7,326|
|2019-06-05||Harsh Michael (Director)||Buy||100||1.20||120|
|2019-05-16||Thornton Michael Milos (Chief Technology Officer)||Buy||30,000||1.13||33,900|
Insider trading activities including stock purchases, stock sales, and option exercises of NDRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endra Life Sciences Inc. (symbol NDRA, CIK number 1681682) see the Securities and Exchange Commission (SEC) website.